Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies

被引：0
|
作者：
Yu, Li-Li [1 ,2 ]
He, Zhi-Lin [1 ,2 ]
Qian, Xin-Lai [1 ,2 ]
机构：
[1] Xinxiang Med Univ, Affiliated Hosp 3, Dept Pathol, Xinxiang 453003, Henan, Peoples R China
[2] Xinxiang Med Univ, Dept Basic Med Sci, 601 Jinsui Rd, Xinxiang 453003, Henan, Peoples R China
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2024年 / 30卷 / 24期
基金：
中国国家自然科学基金;
关键词：
Immunotherapy; Immune checkpoint inhibitor; Immune checkpoint inhibitor-related gastritis; Immune-related adverse events; Autoimmune responses;
D O I：
10.3748/wjg.v30.i24.3120
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Immune checkpoint inhibitors (ICIs) are widely used due to their effectiveness in treating various tumors. Immune-related adverse events (irAEs) are defined as adverse effects resulting from ICI treatment. Gastrointestinal irAEs are a common type of irAEs characterized by intestinal side effects, such as diarrhea and colitis, which may lead to the discontinuation of ICIs
引用
收藏
页码：3120 / 3122
页数：4
相关论文
共 50 条
  • [41] Mediators and mechanisms of immune checkpoint inhibitor-associated myocarditis: Insights from mouse and human
    Gong, Jingyi
    Neilan, Tomas G.
    Zlotoff, Daniel A.
    IMMUNOLOGICAL REVIEWS, 2023, 318 (01) : 70 - 80
  • [42] Reporting of immune checkpoint inhibitor-associated myocarditis Reply
    Moslehi, Javid J.
    Salem, Joe-Elie
    Sosman, Jeffrey A.
    Lebrun-Vignes, Benedicte
    Johnson, Douglas B.
    LANCET, 2018, 392 (10145): : 384 - 385
  • [43] Tofacitinib for the treatment of refractory immune checkpoint inhibitor-associated immune nephritis
    Shivaraj, Kiran
    Tchakarov, Amanda
    Dong, Yanlan
    Lin, Jamie S.
    CLINICAL KIDNEY JOURNAL, 2024, 17 (05)
  • [44] Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists
    Frigeri, Mauro
    Meyer, Philippe
    Banfi, Carlo
    Giraud, Raphael
    Hachulla, Anne-Lise
    Spoerl, David
    Friedlaender, Alex
    Pugliesi-Rinaldi, Angela
    Dietrich, Pierre-Yves
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (01) : 92.e1 - 92.e3
  • [45] Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis
    Doms, J.
    Prior, J. O.
    Peters, S.
    Obeid, M.
    ANNALS OF ONCOLOGY, 2020, 31 (09) : 1273 - 1275
  • [46] Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes
    Dow, Eliot R.
    Yung, Madeline
    Tsui, Edmund
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (01) : 203 - 211
  • [47] A case of immune checkpoint inhibitor-associated gastroenteritis detected by ultrasonography
    Omotehara, Satomi
    Nishida, Mutsumi
    Yamanashi, Kana
    Sakurai, Kensuke
    Katsurada, Takehiko
    Komatsu, Yoshito
    Shimizu, Ai
    Shibuya, Hitoshi
    Shinagawa, Naofumi
    Sugita, Junichi
    Teshima, Takanori
    JOURNAL OF CLINICAL ULTRASOUND, 2021, 49 (06) : 605 - 609
  • [48] Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review
    Pradhan, Richeek
    Nautiyal, Amit
    Singh, Sonal
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 296 : 113 - 121
  • [49] Recent advances in the study of immune checkpoint inhibitor-associated pneumonia
    Feng, Xiaoan
    Li, Guohui
    Li, Chunyu
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 206
  • [50] Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction
    Wright, Jordan J.
    Johnson, Douglas B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (06): : 1514 - 1525
12345